Every material Form 8-K Exponent filed with the SEC in 2026, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
Exponent reported third-quarter 2026 total revenues up 18% to $173.7 million and net income of $30.9 million, or $0.64 per diluted share, compared with $0.55 a year earlier. The company raised its full-year 2026 revenue and margin guidance and declared a $0.31 quarterly dividend payable December 18, 2026.
Revenues before reimbursements rose 12% to $153.1 million; EBITDA was $45.0 million, or 29.4% of those revenues.
Full-year 2026 outlook: revenues before reimbursements to grow 10% to 11%, and EBITDA to be 28.0% to 28.3% of revenues before reimbursements.
Fourth-quarter 2026 outlook: revenues before reimbursements to grow 8% to 10%, and EBITDA to be 26.3% to 26.8% of revenues before reimbursements.
Quarterly cash dividend of $0.31 per share, with a record date of December 4, 2026 and payment on December 18, 2026.
Exponent reported second-quarter 2026 results for the quarter ended July 3, 2026, with total revenues up 21% to $171.6 million and net income up to $29.4 million, or $0.60 per diluted share, from $0.52 a year earlier. The company raised its full-year 2026 revenue growth and EBITDA margin guidance and declared a $0.31 quarterly dividend and an additional $50 million share repurchase authorization.
Q2 revenues before reimbursements rose 12% to $148.9 million; net income was $29.4 million, or $0.60 per diluted share, versus $26.6 million, or $0.52, in Q2 2025.
Full-year 2026 guidance raised: revenues before reimbursements to grow 9% to 10%, and EBITDA to be 27.8% to 28.1% of revenues before reimbursements.
Third-quarter 2026 outlook: revenues before reimbursements expected to grow 8% to 10%, with EBITDA at 28.0% to 28.5% of revenues before reimbursements.
Quarterly dividend of $0.31 per share is payable September 18, 2026, to holders of record as of September 4, 2026; the buyback authorization was increased by $50 million.
Exponent reported first-quarter fiscal 2026 results with total revenues up 14% to $166.3 million and net income up to $29.6 million, or $0.59 per diluted share, from $0.52 a year earlier. The company maintained its full-year 2026 guidance and set a quarterly dividend of $0.31 per share, while its Board added $50 million to the share repurchase authorization.
Revenues before reimbursements rose 10% to $151.8 million; total revenues rose 14% to $166.3 million.
Net income was $29.6 million, or $0.59 per diluted share, versus $26.7 million, or $0.52, a year earlier.
EBITDA rose to $43.1 million, or 28.4% of net revenues, from $37.5 million, or 27.3%.
Dividend of $0.31 per share is payable June 18, 2026 to holders of record as of June 5, 2026; $17.7 million remained for repurchases as of April 3, 2026, before the $50 million increase.
Exponent, Inc. (EXPO) said its board appointed John Pye, Ph.D., as President and Eric Anderson as Chief Financial Officer, both effective May 1, 2026, and both will report to CEO Catherine Corrigan. Current CFO Richard Schlenker will remain Executive Vice President and has been nominated for election to the board, while director Paul Johnston retires and Karen Richardson becomes Chairman at the June 4, 2026 annual meeting.
John Pye, who joined the company in 1999 and is currently Vice President of Global Offices and Innovation, becomes President effective May 1, 2026, with a base salary of $650,000 and a stock option grant covering 21,000 shares.
Eric Anderson, Vice President of Finance and Accounting since 2024 and a company employee since 2003, becomes Chief Financial Officer effective May 1, 2026, with a base salary of $525,000 and a stock option grant covering 12,600 shares.
Richard Schlenker stops being Chief Financial Officer on May 1, 2026, stays on as Executive Vice President, and has been nominated to stand for election to the board.
Paul Johnston retires from the board at the Annual Meeting of Stockholders on June 4, 2026, and Karen Richardson, the Lead Independent Director, will then become Chairman.
Exponent reported fourth-quarter 2025 revenue up 7.8% to $147.4 million and net income of $24.8 million, or $0.49 per diluted share, versus $0.46 a year earlier. For fiscal 2025, net income fell to $106.0 million, or $2.07 per diluted share, from $109.0 million, or $2.11, even as revenue rose 4.2%, and the company expects high-single-digit revenue growth in fiscal 2026. The board also raised the quarterly dividend from $0.30 to $0.31 per share.
Q4 2025 total revenues rose 7.8% to $147.4 million; the quarter had 13 weeks versus 14 weeks in Q4 2024.
Fiscal 2025 net income was $106.0 million, or $2.07 per diluted share, versus $109.0 million, or $2.11, in fiscal 2024.
For fiscal 2026, Exponent expects revenues before reimbursements to grow in the high-single digits, with EBITDA of 27.6% to 28.1% of revenues before reimbursements.
Quarterly dividend increased from $0.30 to $0.31 per share, payable March 20, 2026, to holders of record as of March 6, 2026.
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every Exponent filing is on SEC EDGAR ↗. 8-K briefs of other companies →